News Conference News CRT 2024 CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care L.A. McKeown March 20, 2024
News Daily News FDA Approves Aprocitentan for Inadequately Controlled Hypertension Michael O'Riordan March 20, 2024
News Conference News CRT 2024 Comprehensive Radiation Shield Sharply Cuts Operator Exposure L.A. McKeown March 19, 2024
News Daily News US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users Caitlin E. Cox March 18, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Conference News CRT 2024 SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI L.A. McKeown March 15, 2024
News Daily News Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes Caitlin E. Cox March 12, 2024
News Daily News AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead Yael L. Maxwell March 07, 2024
News Daily News Plastic Debris Found in Carotid Plaque Linked to More Adverse CV Events L.A. McKeown March 06, 2024
News Daily News Just a Few Thousand Steps Can Help Reduce CV Harms of Sitting Caitlin E. Cox March 06, 2024
News Daily News Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial Todd Neale March 04, 2024
News Daily News High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention Michael O'Riordan February 29, 2024
News Daily News Living Near Bars, Restaurants Linked to Greater Likelihood of HF L.A. McKeown February 29, 2024
News Daily News More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality Caitlin E. Cox February 28, 2024
News Daily News Cannabis Use Tied to Greater Risks of MI, Stroke in a Large Study Todd Neale February 28, 2024
News Daily News High Lp(a) Levels Harmful in Patients With and Without ASCVD Michael O'Riordan February 27, 2024
News Daily News Infective Endocarditis in Opioid Users: Care Must Go Beyond the Heart Caitlin E. Cox February 26, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024